BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

587 related articles for article (PubMed ID: 20039311)

  • 1. Osteoclast-specific Dicer gene deficiency suppresses osteoclastic bone resorption.
    Mizoguchi F; Izu Y; Hayata T; Hemmi H; Nakashima K; Nakamura T; Kato S; Miyasaka N; Ezura Y; Noda M
    J Cell Biochem; 2010 Apr; 109(5):866-75. PubMed ID: 20039311
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of dimeric glucocorticoid receptors in osteoclast progenitors potentiates RANKL induced mature osteoclast bone resorbing activity.
    Conaway HH; Henning P; Lie A; Tuckermann J; Lerner UH
    Bone; 2016 Dec; 93():43-54. PubMed ID: 27596806
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA-338-3p inhibits glucocorticoid-induced osteoclast formation through RANKL targeting.
    Zhang XH; Geng GL; Su B; Liang CP; Wang F; Bao JC
    Genet Mol Res; 2016 Aug; 15(3):. PubMed ID: 27706599
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The cross-talk between osteoclasts and osteoblasts in response to strontium treatment: involvement of osteoprotegerin.
    Peng S; Liu XS; Huang S; Li Z; Pan H; Zhen W; Luk KD; Guo XE; Lu WW
    Bone; 2011 Dec; 49(6):1290-8. PubMed ID: 21925296
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progressive ankylosis protein (ANK) in osteoblasts and osteoclasts controls bone formation and bone remodeling.
    Kim HJ; Minashima T; McCarthy EF; Winkles JA; Kirsch T
    J Bone Miner Res; 2010 Aug; 25(8):1771-83. PubMed ID: 20200976
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Caffeic acid 3,4-dihydroxy-phenethyl ester suppresses receptor activator of NF-κB ligand–induced osteoclastogenesis and prevents ovariectomy-induced bone loss through inhibition of mitogen-activated protein kinase/activator protein 1 and Ca2+–nuclear factor of activated T-cells cytoplasmic 1 signaling pathways.
    Wu X; Li Z; Yang Z; Zheng C; Jing J; Chen Y; Ye X; Lian X; Qiu W; Yang F; Tang J; Xiao J; Liu M; Luo J
    J Bone Miner Res; 2012 Jun; 27(6):1298-1308. PubMed ID: 22337253
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dok-1 and Dok-2 deficiency induces osteopenia via activation of osteoclasts.
    Kawamata A; Inoue A; Miyajima D; Hemmi H; Mashima R; Hayata T; Ezura Y; Amagasa T; Yamanashi Y; Noda M
    J Cell Physiol; 2011 Dec; 226(12):3087-93. PubMed ID: 21732353
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impaired micro-RNA pathways diminish osteoclast differentiation and function.
    Sugatani T; Hruska KA
    J Biol Chem; 2009 Feb; 284(7):4667-78. PubMed ID: 19059913
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dicer ablation in osteoblasts by Runx2 driven cre-loxP recombination affects bone integrity, but not glucocorticoid-induced suppression of bone formation.
    Liu P; Baumgart M; Groth M; Wittmann J; Jäck HM; Platzer M; Tuckermann JP; Baschant U
    Sci Rep; 2016 Aug; 6():32112. PubMed ID: 27554624
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Positive regulation of osteogenesis by bile acid through FXR.
    Cho SW; An JH; Park H; Yang JY; Choi HJ; Kim SW; Park YJ; Kim SY; Yim M; Baek WY; Kim JE; Shin CS
    J Bone Miner Res; 2013 Oct; 28(10):2109-21. PubMed ID: 23609136
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Absence of bone sialoprotein (BSP) impairs primary bone formation and resorption: the marrow ablation model under PTH challenge.
    Wade-Gueye NM; Boudiffa M; Vanden-Bossche A; Laroche N; Aubin JE; Vico L; Lafage-Proust MH; Malaval L
    Bone; 2012 May; 50(5):1064-73. PubMed ID: 22586700
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deletion of FGFR3 in Osteoclast Lineage Cells Results in Increased Bone Mass in Mice by Inhibiting Osteoclastic Bone Resorption.
    Su N; Li X; Tang Y; Yang J; Wen X; Guo J; Tang J; Du X; Chen L
    J Bone Miner Res; 2016 Sep; 31(9):1676-87. PubMed ID: 26990430
    [TBL] [Abstract][Full Text] [Related]  

  • 13. p130Cas, Crk-associated substrate, plays important roles in osteoclastic bone resorption.
    Nagai Y; Osawa K; Fukushima H; Tamura Y; Aoki K; Ohya K; Yasuda H; Hikiji H; Takahashi M; Seta Y; Seo S; Kurokawa M; Kato S; Honda H; Nakamura I; Maki K; Jimi E
    J Bone Miner Res; 2013 Dec; 28(12):2449-62. PubMed ID: 23526406
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Conditional deletion of Bmpr1a in differentiated osteoclasts increases osteoblastic bone formation, increasing volume of remodeling bone in mice.
    Okamoto M; Murai J; Imai Y; Ikegami D; Kamiya N; Kato S; Mishina Y; Yoshikawa H; Tsumaki N
    J Bone Miner Res; 2011 Oct; 26(10):2511-22. PubMed ID: 21786321
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppression Effect of Astaxanthin on Osteoclast Formation In Vitro and Bone Loss In Vivo.
    Hwang YH; Kim KJ; Kim SJ; Mun SK; Hong SG; Son YJ; Yee ST
    Int J Mol Sci; 2018 Mar; 19(3):. PubMed ID: 29562730
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dicer inactivation in osteoprogenitor cells compromises fetal survival and bone formation, while excision in differentiated osteoblasts increases bone mass in the adult mouse.
    Gaur T; Hussain S; Mudhasani R; Parulkar I; Colby JL; Frederick D; Kream BE; van Wijnen AJ; Stein JL; Stein GS; Jones SN; Lian JB
    Dev Biol; 2010 Apr; 340(1):10-21. PubMed ID: 20079730
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heat shock protein 60 causes osteoclastic bone resorption via toll-like receptor-2 in estrogen deficiency.
    Koh JM; Lee YS; Kim YS; Park SH; Lee SH; Kim HH; Lee MS; Lee KU; Kim GS
    Bone; 2009 Oct; 45(4):650-60. PubMed ID: 19527807
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lrp4 in osteoblasts suppresses bone formation and promotes osteoclastogenesis and bone resorption.
    Xiong L; Jung JU; Wu H; Xia WF; Pan JX; Shen C; Mei L; Xiong WC
    Proc Natl Acad Sci U S A; 2015 Mar; 112(11):3487-92. PubMed ID: 25733894
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Melatonin at pharmacologic doses increases bone mass by suppressing resorption through down-regulation of the RANKL-mediated osteoclast formation and activation.
    Koyama H; Nakade O; Takada Y; Kaku T; Lau KH
    J Bone Miner Res; 2002 Jul; 17(7):1219-29. PubMed ID: 12096835
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The large zinc finger protein ZAS3 is a critical modulator of osteoclastogenesis.
    Liu S; Madiai F; Hackshaw KV; Allen CE; Carl J; Huschart E; Karanfilov C; Litsky A; Hickey CJ; Marcucci G; Huja S; Agarwal S; Yu J; Caligiuri MA; Wu LC
    PLoS One; 2011 Mar; 6(3):e17161. PubMed ID: 21390242
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.